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Background:New-onset Alzheimer disease (AD) is of-
ten attributed to degenerative changes in the hippocam-
pus. However, the contribution of regionally distrib-
uted small vessel cerebrovascular disease, visualized as
whitematter hyperintensities (WMHs) onmagnetic reso-
nance imaging, remains unclear.
Objective: To determine whether regional WMHs and
hippocampal volume predict incident AD in an epide-
miological study.
Design:A longitudinal community-based epidemiologi-
cal study of older adults from northernManhattan, New
York.
Setting: The Washington Heights/Inwood Columbia
Aging Project.
Participants: Between 2005 and 2007, 717 partici-
pants without dementia received magnetic resonance
imaging scans. Amean (SD) of 40.28 (9.77)months later,
503 returned for follow-up clinical examination and 46
met criteria for incident dementia (45 with AD). Re-
gional WMHs and relative hippocampal volumes were
derived. Three Cox proportional hazards models were
run to predict incident dementia, controlling for rel-
evant variables. The first included all WMH measure-
ments; the second included relative hippocampal vol-
ume; and the third combined the 2 measurements.
Main Outcome Measure: Incident AD.
Results:White matter hyperintensity volume in the pa-
rietal lobe predicted time to incident dementia (hazard
ratio [HR]=1.194; P=.03). Relative hippocampal vol-
ume did not predict incident dementia when consid-
ered alone (HR=0.419; P=.77) or with the WMH mea-
sures included in the model (HR=0.302; P= .70).
Including hippocampal volume in themodel did not no-
tably alter the predictive utility of parietal lobe WMHs
(HR=1.197; P=.049).
Conclusions: The findings highlight the regional speci-
ficity of the association of WMHs with AD. It is not clear
whether parietalWMHs solely represent amarker for cere-
brovascular burden or point to distinct injury compared
with other regions. Future work should elucidate patho-
genic mechanisms linking WMHs and AD pathology.
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A MONG THE MOST SIGNIFI-cant advances in Alzhei-mer disease (AD) researchover the past 20 years hasbeen the integration of bio-
logically relevant data with well-defined
clinical information. High-resolution neu-
roimaging techniques have been at the
forefront, allowing for the appreciation of
structural and functional changes in the
aging brain thatmight provide insights into
the pathogenic mechanisms of the dis-
ease, operationally defined biological
markers of disease state, and clues about
strategies for disease prevention. In re-
cent years, data from structural magnetic
resonance imaging (MRI) and positron
emission tomography (PET) coupledwith
cognitive data and clinical diagnosis have
suggested a cascade of biological events
that ultimately lead to the neuropsycho-
logical syndrome attributed to AD. These
data were synthesized in an influential
report by Jack and colleagues1 that of-
fered a hypotheticalmodel of dynamicAD-
related biomarkers. According to the
model, abnormal -amyloid processing
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leads to brain amyloidosis, precipitating tau-related neu-
ronal and synaptic dysfunction, and neurodegenera-
tion, which manifest ultimately as cognitive decline and
dementia. The putative biological changes are ostensi-
bly reflected in neuroimaging-derived markers, includ-
ing amyloid “positivity” in cortical regions on PET; re-
gional hypometabolism on fluorodeoxyglucose PET; and
medial temporal lobe atrophy on MRI. The model pro-
vides a framework to test hypotheses regarding the tem-
poral ordering of biological changes and influence of other
relevant factors in prospective research studies.
However, despite fairly consistent observations show-
ing a relationship between vascular disease and AD,2 vas-
cular factors have not been incorporated formally into
the proposed theoretical model of AD pathogenesis1 or
newly proposed research criteria for AD and its anteced-
ent conditions,3-5 although most of the major identified
risk factors for later development of AD have been vas-
cular in nature.6 The gradual accumulation of these vas-
cular risk factors manifests in the brain as small vessel
cerebrovascular disease, visualized as hyperintense sig-
nal, or white matter hyperintensities (WMHs), on T2-
weightedMRI.7 Because peripheral vascular disease is of-
ten treated successfully and ascertainment of vascular
disease history via medical interview may be unreliable,
MRI assessment of WMHs may provide the most direct
measurement of cerebrovascular damage. White matter
hyperintensity burden, particularly in posterior brain re-
gions, is elevated in individuals at risk for AD and with
prevalent AD8 and predicts the rate of cognitive decline
among individuals with AD.9 Although some population-
based reports suggest thatWMHburden is associatedwith
future development of AD,10 it is unclear whether this
association is independent of hypothesized biological etio-
logicalmarkers (eg, hippocampus atrophy), whichwould
suggest a role of small vessel cerebrovascular disease in
the pathogenesis of the disease.
Herein,we sought to determinewhether regionally dis-
tributed WMH volume and hippocampal atrophy inde-
pendently predict incident AD in a community-based co-
hort of older adults without dementia. Consistent with
the prevailing hypothesized pathogenic model of AD,1
we hypothesized that degree of hippocampal atrophy
would be associated with incident AD. We also hypoth-
esized that WMH volume, particularly in posterior re-
gions, would be associated with incident AD, reflecting
the contributing role of cerebrovascular disease.
METHODS
PARTICIPANTS
Subjects were participants in theWashington Heights/Inwood
Columbia Aging Project (WHICAP), an ongoing longitudinal
community-based study of aging anddementia in northernMan-
hattan, New York. They were recruited at 2 points beginning
in 1992 and 1999.11 Members of the study cohort received a
full medical, neurological, and neuropsychological examina-
tion at each of the follow-up visits, which occurred every 18 to
24 months. Beginning in 2004, active participants (n=2776)
who did not meet criteria for dementia at their preceding fol-
low-up visit were invited to participate in anMRI study.12 Briefly,
769 underwent MRI. Compared with the 407 cohort members
whowere eligible for MRI but refused participation, those who
received MRI scans were 1 year older, more likely to be fe-
male, and more likely to be African American. Among the 769
individuals with MRI scanning, 52 met diagnostic criteria for
dementia at the clinical visit that was closest to the MRI scan
and were thus excluded from analyses. This study was ap-
proved by an institutional ethics committee and all partici-
pants gave written informed consent to participate.
For the purposes of this report, we refer to “baseline” as the
visit that was contemporaneous with theMRI scan and “follow-
up” as the subsequent visit. Of the 717 participants without
dementia with MRI seen at baseline, 503 (70.2%) were seen at
follow-up. Reasons for lack of follow-up assessment include re-
fusal (n=37) and participant moved out of the area (n=19),
was confirmed deceased (n=46), or was lost to follow-up
(n=131). Additionally, data from 34 participants were ex-
cluded from analyses because scan artifact or image quality pre-
cluded the quantification ofWMHs (n=11), hippocampal vol-
ume (n=17), or both (n=6).
DIAGNOSTIC PROCEDURES
Participants underwent in-person evaluation at each fol-
low-up visit, which includedmedical history, physical and neu-
rological examination, and neuropsychological testing. The neu-
ropsychological battery comprises measures of memory,
orientation, language, abstract reasoning, and visuospatial13 and
has been shown to measure equivalent traits across the 2 lan-
guage groups represented in the study population.14 The diag-
nosis of dementia was established using all available clinical
information (apart from neuroimaging data) and was based on
standard research criteria.15 Following each clinical evalua-
tion, a consensus conference that included physicians and neu-
ropsychologists reviewed all available data. First, a diagnosis
of dementia was made15 and then the etiology was determined
based on research criteria for probable or possible AD,16 Lewy
body dementia,17 vascular dementia,18 and other dementias.
Additionally, history of diabetesmellitus, hypertension, heart
disease, and clinical stroke was ascertained by self-report.12,19
These 4 dichotomous variables were summed to create a vas-
cular history score (score range, 0-4).12
MAGNETIC RESONANCE IMAGING
Procedures regarding MRI scanning have been described pre-
viously.12Magnetic resonance imaging scan acquisitionwas per-
formed on a 1.5-T Philips Intera scanner at Columbia Univer-
sity. For quantification of hippocampal, total cranial, andWMH
volume, T1-weighted (repetition time=20 milliseconds, echo
time=2.1 milliseconds, field of view=240 cm, 256160 ma-
trix, and 1.3 mm slice thickness) and T2-weighted fluid-
attenuated inversion recovery (FLAIR) (repetition time=11 000
milliseconds, echo time=144.0 milliseconds, inversion
time=2800 milliseconds, field of view=25 cm, number of ex-
citations=2, and 256192 matrix with 3 mm slice thickness)
images were acquired in the axial orientation. Regional WMH
volumes were derived following procedures developed in our
laboratory.20,21 Briefly, FLAIR images were skull stripped. A
Gaussian curve was fit to map the voxel intensity values and
WMHs were seeded by labeling voxels that were more than 3
SD of the image mean. Each seed was passed through an itera-
tive mean intensity–based seed growing algorithm using a 10-
point connectivity scheme. This approach labels adjacent vox-
els that fall within 5% of the mean intensity value of the seed,
continuing iteratively, such that labeled voxels are added to the
image and a new seed mean is created. To derive WMH vol-
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umes in the frontal, temporal, parietal, and occipital lobes, a
standard “lobar” atlas22 was spatially normalized to each sub-
ject’s labeled FLAIR image. Regional volumes were defined by
the intersection of each atlas lobe with the labeled WMH vox-
els in that region; labeled voxel values weremultiplied by voxel
dimensions and summed to yield volumes in cm3.
Hippocampal volume and total cranial volumes were de-
rived manually at University of California, Davis.12 The T1-
weighted images were reoriented in the coronal plane. Bound-
aries were placed along the borders of the hippocampus as
previously described.12 Intrarater reliabilities for the left and
right hippocampus were good (intraclass correlation coeffi-
cients: 0.98 and 0.96).
Total cranial volume was determined manually12 by trac-
ing the dura mater within the cranial vault on the FLAIR MRI.
The number of voxels contained within the traced space was
multiplied by the voxel dimensions to yield a single volume
value. We derived the relative hippocampal volume, a mea-
sure of hippocampal atrophy, by dividing the sum of the left
and right hippocampal volume by total cranial volume andmul-
tiplying that value by 100.
STATISTICAL ANALYSES
We used t tests, 2 analysis, and the Mann-Whitney U test to
compare demographic features, including age, years of educa-
tion, sex distribution, ethnic/race distribution, presence of the
APOE ε4 allele, individual vascular risk factors, and vascular
history scores at baseline between participants who were in-
cluded in the analyses (n=503) and those who were not in-
cluded based on loss to follow-up (n=214). Descriptive statis-
ticswere generated for the samedemographic features at baseline
in the total sample and compared between participants whomet
criteria for incident dementia at follow-up and those who re-
mained without dementia. We examined the average time be-
tween the MRI scan and the baseline clinical evaluation and
the average time between theMRI scan and the follow-up visit.
Participants with incident dementia and those who remained
without dementia throughout follow-upwere compared for base-
line differences in hippocampal and regionalWMHvolumewith
general linear models controlling for age at baseline, sex, edu-
cation, presence of the APOE ε4 allele, and ethnicity.
Three Cox proportional hazards models were constructed
to address the primary aims of the study. The first determined
whether the regional distribution ofWMHs predicted the time
to incident dementia, or cumulative “survival.” The incident
dementia date was defined as the halfway point between the
date of the MRI scan and the follow-up visit in which the di-
agnosis of dementia was made. However, all primary analyses
were also run with the incident dementia date corresponding
to the date of follow-up evaluation in which the diagnosis of
dementia was made, and the findings were not notably al-
tered.White matter hyperintensity volumes in all regions were
entered simultaneously in the model as continuous predic-
tors. Additional covariates included age (at baseline), sex, edu-
cation (in years), presence of the APOE ε4 allele, and race/
ethnicity. For race/ethnicity, Hispanic and black were entered
as individual dichotomous variables, with non-Hispanic white
as the reference. In the secondmodel, relative hippocampal vol-
ume was entered rather than the regional WMH volume mea-
surements. The third model contained both WMH and rela-
tive hippocampal volume entered simultaneously, along with
the other covariates noted earlier, to examine the independent
contributions of each predictive factor. The third model was
also rerun with the vascular history score as an additional
covariate.
RESULTS
Compared with those who were excluded from analy-
ses, participants who were included were about a year
younger (mean [SD] age, 79.66 [5.20] years vs 80.99
[6.18] years; t715=2.970; P=.003) and comprised a greater
proportionofwomen (69.7%vs 62.2%;21=3.986;P=.046)
but were similar in number of years of education (mean
[SD], 10.58 [4.37] years vs 10.80 [4.97] years; t713=0.569;
P=.57), race/ethnicity distribution (32.1%AfricanAmeri-
can, 38.3% Hispanic vs 40.5% African American, 31.9%
Hispanic; 22=4.901; P=.09), and presence of the APOE
ε4 allele (24.3% vs 30.3%, 21=2.779; P=.10). Those in-
cluded in the analyses had higher rates of hypertension
(68.8% vs 61.2%; 21=3.87; P=.049) but similar rates of
diabetes (21=0.80; P= .37), heart disease (21=0.029;
P=.87), and stroke (21=3.71; P=.054) than those who
were not.
Forty-six participants met criteria for dementia at the
follow-up visit; 45 of these individuals met criteria for
probable AD (n=27 probable AD; n=6 probable ADwith
stroke; n=2 probableADwith Parkinson disease; and n=9
probable ADwith other concomitant disease) and 1met
criteria for dementia with Lewy bodies. Table 1 dis-
plays demographic differences between incident demen-
tia cases and those who remained without dementia. Pa-
tients with incident dementia were older, had fewer years
of education, and were more likely to be Hispanic but
had similarAPOE ε4 frequency and interval between base-
lineMRI and baseline clinical evaluation and between fol-
low-up clinical evaluation and baselineMRI. Hippocam-
pal volume did not differ between the 2 groups at baseline
(F1,435=0.339; P=.56). Overall WMH volume (main ef-
fect of diagnostic group: F1,441=0.258; P=.61) and re-
gional WMH volume (diagnostic groupregion inter-
action: F3,1323=0.534; P=.66) at baseline did not vary as
a function of diagnostic group.
Table 2 displays the results from the Cox propor-
tional hazards models. White matter hyperintensity
volume in the parietal lobe predicted the time to inci-
dent dementia, whereas distribution of WMHs in
other regions did not (omnibus model 210 = 27.870;
P = .002). Interpretation of the hazards ratio suggests
that for every 1-cm3 increase in WMH volume in the
parietal lobe there is an associated 19% increase in the
risk of incident dementia. Of the other covariates in
the model, only increased age and decreased education
were associated with incident dementia. It is notable
that the hazard ratio for parietal lobe WMHs was
larger than the one for age (Table 2). In the second
model, in which relative hippocampus volume was
entered instead of the regional WMH measurements,
only age and education emerged as reliable predictors
of incident dementia (omnibus model 27 = 20.101;
P = .005). While greater hippocampus atrophy was
associated with a greater risk for incident dementia,
the observation was not significant. The third model,
in which regional WMH volumes and relative hippo-
campal volume were entered simultaneously, showed
that only increased WMH volume in the parietal lobes,
age, and education were associated with an increased
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risk of incident dementia. For illustration purposes,
the Figure displays cumulative survival curves for
individuals with high WMH volumes in the parietal
lobe as compared with the rest of the sample. The
models were rerun with a parietal lobe WMH  hip-
pocampus volume interaction term, which did not
emerge as a significant predictor. When the vascular
history score was entered as an additional covariate, it
was not associated with incident dementia nor did it
notably alter the hazard ratio for parietal lobe WMH
(ie, 1.19 vs 1.17).
COMMENT
In this community-based, multiethnic group cohort of
older adults, we found that WMH volume in the pari-
etal lobes predicted incident AD, whileWMH volume in
other areas and hippocampal volume did not. The find-
ings suggest, perhaps, a primary pathogenic role of small
vessel cerebrovascular disease in AD, which is indepen-
dent of the neurodegenerative changes ostensibly re-
flected in measures of hippocampal atrophy. Surpris-
ingly, hippocampal atrophy at baseline did not predict
incident dementia in this cohort either when consid-
ered alone or in the context of WMHs.
Although previously thought to be of little clinical rel-
evance, WMHs have emerged in recent years as particu-
larly salient radiological correlates of cognitive aging. Our
observation thatWMHs predict future AD is in line with
other recent studies that have shown increased WMHs
in prevalent AD andmild cognitive impairment,8 as well
as recent observations that WMHs predict rate of cogni-
tive decline among individuals with prevalent AD.9White
matter hyperintensities are thought to reflect small ves-
sel cerebrovascular disease that is primarily ischemic in
nature,23 but relatively few clinic-pathological corre-
lates studies have been conducted, and although appear-
ing as relatively homogenous signal on MRI scans, the
regional distribution might reflect varying pathological
features.20,24
That our findings were restricted to the parietal lobes
raises questions about the unique role parietal lobe pa-
thology may play in the clinical expression of AD. The
parietal lobes have been differentially implicated in the
disease since Alois Alzheimer’s second case study (Jo-
hann F.) in 1911, in which plaques were described to be
“. . . present in enormous numbers in the parietal”
lobe.25(p116) White matter hyperintensities distributed in
parietal lobe networks have been shown to be related to
cognitive decline among individuals with mild cogni-
tive impairment26 and cross-sectionally to AD diagno-
sis.8 Positron emission tomography–derived glucose hy-
pometabolism and lobar microbleeds, which reflect
cerebral amyloid angiopathy, tend to colocalize in pos-
terior brain regions, particularly the parietal lobes, in the
context of AD or risk of AD.27-31 It is unclear why the pa-











(n = 503) Statistics P Value
Age at baseline, y, mean (SD) 79.41 (5.12) 82.15 (5.55) 79.66 (5.20) t501 = 3.434 .001




2 = 7.083 .03
White/other 30.2 21.7 29.6
African American 33.2 21.7 32.1
Hispanic 36.5 56.5 38.3
APOE ε4 frequency, % 24.4 22.7 24.3 21 = 0.062 .80
Vascular risk factors, %
Diabetes mellitus 21.0 23.9 21.3 21 = 0.211 .65
Hypertension 69.1 65.2 68.8 21 = 0.301 .58
Heart disease 22.5 17.4 22.1 21 = 0.644 .42
Stroke 9.8 15.2 10.3 21 = 1.300 .25
Vascular history score, median 1 1 1 Mann-Whitney U = 10 242.50 .76
Time between MRI scan
and baseline evaluation,
mo, mean (SD)
0.96 (5.27) 1.61 (7.05) 0.79 (6.25) t499 = 0.766 .44
Time between MRI scan
and follow-up visit, mo,
mean (SD)
40.18 (9.68) 41.63 (10.69) 40.28 (9.77) t474 = 0.911 .36
Regional WMH volume,
cm3, mean (SD)
Frontal 1.69 (3.19) 2.04 (2.84) 1.70 (3.16)
Diagnostic group: F1,441 = 0.258;
group  region: F3,1323 = 0.534
.61; .66
Temporal 0.12 (0.28) 0.13 (0.23) 0.12 (0.27)
Parietal 1.24 (2.48) 1.77 (2.55) 1.29 (2.49)
Occipital 0.16 (0.38) 0.13 (0.17) 0.15 (0.37)
Relative hippocampus
volume, mean (SD)
0.29 (0.06) 0.28 (0.07) 0.29 (0.06) F1,435 = 0.339 .56
Abbreviations: MRI, magnetic resonance imaging; WMH, white matter hyperintensity.
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rietal lobes per se appear to have a particular vulnerabil-
ity, but this converging evidence across modalities and
pathological markers highlights the importance of fur-
ther study on the regional distribution of WMHs. It is
possible thatWMHs distributed in parietal regions com-
prise mixed pathology, which may interact mechanisti-
cally with other neurodegenerative processes. Further
work examining pathogenic links between white matter
pathology and primaryADpathology is clearlywarranted.
We hypothesized that detectable hippocampal atro-
phy would precede cognitive and functional decline at-
tributable to AD and would thus predict future incident
AD diagnosis.1 Indeed, there aremyriad examples of hip-
pocampal volume reduction among patients with AD and
those at risk for AD,32 although these studies have gen-
erally focused on clinic-based samples, and the extent to
which hippocampal degeneration has prognostic utility
in population studies remains somewhat unclear. There
are several notable potential explanations for the nega-
tive predictive utility of hippocampal atrophy for inci-
dent AD seen in our community-based study. First, the
sample is older than typical aging and dementia cohorts
and it is possible that within this age group the neuro-
biological underpinnings of the AD phenotype are me-
diated primarily by vascular factors rather than neuro-
degenerative or atrophic changes in the hippocampus.
This idea is supported by autopsy studies that show that
brain pathology related to dementia varies in younger and
older elderly individuals.33 Second and similarly, clinic-
based samples often explicitly exclude participants with
significant vascular disease history; thus, other samples
may be restricted to a subset of participants in whomhip-
pocampal atrophy is more relevant. Third, cross-
sectional calculations of relative hippocampal volumemay
underestimate or overestimate atrophyparticularly among
older adults from diverse backgrounds in whom vari-
ance in brain morphology may reflect a combination of
developmental and degenerative processes. Follow-up
workwill measure longitudinal rates of hippocampal vol-
ume change to better characterize rates of atrophic changes
in the hippocampus.
This work has implications for both pathogenic
models of AD as well as current diagnostic criteria. In
terms of AD pathogenesis, it is clear that vascular fac-
tors may play a primary role in the clinical presenta-
tion of AD. Whether vascular factors should be incor-
porated formally into pathogenic models of the
disease1 is a matter of some debate, but what is consis-
tent across studies is their contributing role to syn-
drome presentation. These observations have obvious
implications for treatment and prevention strategies as
AD becomes an increasingly salient public health
problem and as prevalence of vascular disease
increases throughout the life span.34 In terms of diag-
nosis, newly proposed research criteria for AD explic-
itly note that the diagnostic label of AD “should not be
applied when there is evidence of substantial concomi-
tant cerebrovascular disease.”4(p265) In addition to a
lack of consensus regarding operational definitions of
“substantial concomitant cerebrovascular disease,”
excluding individuals with evidence of cerebrovascu-
lar disease may result in rarified samples comprising
only a subset of individuals who are not representative
Table 2. Results From the 3 Cox Proportional Hazard Models
Predictors
Model 1: WMH Only Model 2: Hippocampus Only Model 3: WMH  Hippocampus
HR P Value (95% CI) HR P Value (95% CI) HR P Value (95% CI)
Age 1.078 .02 (1.01-1.15) 1.072 .03 (1.01-1.14) 1.075 .03 (1.01-1.15)
Frontal WMH 0.959 .47 (0.86-1.07) 0.949 .42 (0.84-1.08)
Temporal WMH 0.887 .90 (0.15-5.23) 1.116 .90 (0.19-6.55)
Parietal WMH 1.194 .03 (1.02-1.40) 1.197 .049 (1.01-1.43)
Occipital WMH 0.298 .19 (0.05-1.81) 0.221 .16 (0.03-1.78)
Relative hippocampal volume 0.419 .77 (0.01-134.67) 0.302 .70 (0.01-136.48)
APOE ε4 1.224 .59 (0.58-2.57) 1.054 .90 (0.47-2.35) 1.129 .77 (0.50-2.53)
Sex (1 = female) 1.536 .32 (0.66-3.58) 1.567 .30 (0.67-3.63) 1.378 .46 (0.58-3.25)
Education 0.881 .008 (0.80-0.97) 0.871 .006 (0.79-0.96) 0.870 .006 (0.79-0.96)
Hispanic 0.613 .37 (0.21-1.79) 0.574 .31 (0.20-1.68) 0.543 .28 (0.18-1.65)
Black 0.762 .57 (0.30-1.96) 0.753 .56 (0.29-1.97) 0.657 .41 (0.24-1.78)



























Figure. For illustration, cumulative survival curves were generated that
compared individuals with high white matter hyperintensity volumes in the
parietal lobes, defined here as the top quartile (dotted line), with all other
participants, defined as the bottom 3 quartiles (solid line). MRI indicates
magnetic resonance imaging.
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of the overall population with the syndrome. There is
therefore a risk of “diagnostic prophecy” in which the
etiology of the syndrome is defined by the proposed
inclusion and exclusion criteria of the disease, as
opposed to the opposite scenario in which known
etiological factors are incorporated into more compre-
hensive criteria.
There are several unique aspects of this study that
strengthen the confidence in the results. The WHICAP
cohort is a large, community-based sample that repre-
sents the increasing ethnic and racial diversity that de-
fines the population of older adults in this country. Quan-
titative analysis of high-resolution neuroimaging data is
relatively rare in large community-based studies, par-
ticularly those comprising older adults fromdiverse back-
grounds.35,36 The cohort is neuropsychologicallywell char-
acterized and attrition rates are in line with comparable
large-scale community-based studies. Future work will
incorporate longitudinal neuroimaging data andother bio-
logical markers of disease.
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